Today, on November 14, in St. Petersburg the VIII annual international partnering-forum "Life Sciences Invest started. Partnering Russia". The first day of the Forum brought together nearly 650 people.
Press breakfast "The pharmaceutical industry of the future"
Traditionally business program began with press breakfast "The pharmaceutical industry of the future" where leading experts of the industry, representatives of federal and city authorities, heads of the large pharmaceutical companies and educational institutions met journalists.
Sergey Tsyb, the First Deputy Minister of Industry and Trade of the Russian Federation defined painful points and the directions of development of the industry. According to him, now important task is strengthening of interaction with medical and medical community on all directions. "It is one of the main tasks without which solution we will not receive incentive for development of the industry. Therefore our specialists participate in large medical actions for different nozologiya, the medical directions. Such actions are useful as from the point of view of positioning of the companies, opportunities, competences, and active integration with medicine, strengthenings of cooperation with doctors. We try to increase cooperation with doctors, we attract the main participants of health system – institute of sciences, specialists of the Ministry of Health, those who create the agenda on medical care, the separate strategic directions, specific groups. It is important to inform both specialists, and the population in general that in the country the strong enterprises appeared. In Russia the industrial case according to the most up-to-date international standards which produces complex medicines of any nature forms", - Sergey Tsyb says.
It is necessary to work with popular belief in insolvency of the Russian pharmaceutical industry consistently, Sergey Movchan, the vice governor of St. Petersburg considers. "There is prejudice that if medicine is made in the territory of Russia, then it is medicine not of the best quality. Anything similar! Visiting our leaders – the companies Polisang, Active component, Biokad and others – you see the highest qualitative level of production. Those who were not afraid to invest in production ten years ago, today lifted production of medicines and substances to world level, - Sergey Nikolaevich considers. We have to think of what needs to be made for support of our producers. That it is necessary to make to remove "white spots" the legislation, the medicinal market on the one hand highly profitable, with another – risky,".
According to Pyotr Rodionov, the CEO, the GEROPHARM company, in Russia it is necessary to broaden area of digitalization in pharmaceutics. "Implementation of information systems in health care, in the future will help to solve problem of shortcoming and surplus of drugs in different regions. During creation of systems of the help in adoption of medical decisions the electronic recipe on the basis of which it will be possible to create needs of the region more precisely will be entered. It is one of problems which will be solved in the field of health care in the nearest future", - the expert emphasized.
According to Alexander Semenov, the president of the JSC Aktivny Komponent company, now the enterprises of the industry are faced by ambitious task – strengthening of export of the Russian pharmsubstantion. "For its successful decision it is necessary to change seriously the legislative base and to enter specific incentives of development of export". Nevertheless, Alexander Semenov considers the developed market situation in the world favorable loudly to declare oneself.
Plenary session: "Transition of the industry to the global competition"
In Taleon hotel there took place the ceremonial opening of the VIII International partnering-forum "Life Sciences Invest. Partnering Russia" and plenary session at which experts discussed transition of the pharmaceutical industry to the global competition.
All attendees on behalf of Valentina Matviyenko were welcomed by the assistant to the Chairman of the Federation Council of Federal Assembly of the Russian Federation Lyudmila Kostkina. According to the head of Federal Assembly, faces all global task of production of new medicines, solution of the problem of availability of medicines now.
Sergey Tsyb, the First Deputy Minister of Industry and Trade of the Russian Federation, noted contribution of St. Petersburg to development of the pharmaceutical industry. "St. Petersburg – one of flagman regions in development of pharmotrasla. Here science funding, the industries, cooperation between educational and manufacturing enterprises is actively supported. It is pleasant to me that HIGHER EDUCATION INSTITUTIONS which we supported in due time are in stage of active growth today. It is obvious that formation of highly qualified personnel – the main richness of the Northern Capital", - Sergey Tsyb emphasized.
For the last five years the pharmaceutics shows one of the highest rates of development: in 2014 the output of medicines was a little more than 180 billion rubles, at the end of 2017 – approached 300 billion. "The companies actively invest, develop own portfolios and new competences, opportunities for development of medicines of any nature and complexity", - the deputy minister of the industry declared.
The most important – the companies provide availability of drugs to residents of our country. During implementation of the Seven Nozologiya program which took place under the auspices of the All-Russian union of patients, was succeeded to save about 7 billion rubles from the federal budget at the expense of exit of the Russian medicines.
According to Pyotr Rodionov, the CEO of the GEROPHARM company the Day of fight against diabetes is around the world celebrated today. "At us at forum the round table will be devoted to it. In eight years the industry considerably changed, other level of productions, other quality of medicines", - he emphasized. According to Pyotr Rodionov, in many respects it turned out thanks to Strategy 2020 which on many points is complete ahead of schedule. "The most important that we understand how to build our corporate strategy regarding creation of modern competitive productions. It is obvious that the embodiment of Strategy 2020-2030 will demand serious work on our internal divisions. It is question of competences, any employee has to understand that he creates global product", - Pyotr Rodionov declared.
Success of St. Petersburg as leader of the pharmaceutical industry in is much defined by support of the city authorities, Maxim Meyksin, the chairman of Committee on industrial policy and innovations of St. Petersburg considers. "It seems to me, now in the city the unique situation when the industry feels comfortable is created. It both the SEZ, and industrial platforms for the pharmaceutical companies. In 2019 will be in the city more than 500 companies on production of medical supplies and the equipment will work, it is more", - the chairman of KPPI told. This year at the request of pharmaceutical companies the engineering center is created. "It is very important to grant subsidies, but it is more important to give to develop through the market to the companies", - Maxim Semenovich considers.
Debutants of the Forum - the Company Helikon
For the first time the Company Helikon, the producer and the supplier of the laboratory equipment and expendables for molecular and cell biology participated in the Forum. "Several years we together with regulators, developers, institutes, medical institutions take part in formation of approaches to legislative fixing of norms of creation and the address of biomedical cellular products. We are very glad that from separate private discussions of problematic issues of creation and production of BMKP, we moved to absolutely new level of understanding of perspective. It is promoted also by interaction with representatives of the Ministry of the industry and trade, the Ministry of Health, Committee on industrial policy and innovations of St. Petersburg and so forth.
The accumulated experience, knowledge of the Life Science market, presence of professionals in our team allow to declare themselves as about the leader ready to become the reliable partner for all links of chain in creation, production and application of biomedical cellular products. It is about building of close cooperation between educational and medical institutions, science and production, about further preparation of treatment and prevention facilities for application of the latest cellular developments. Works it is necessary much. Let's begin already here, at forum", - the commercial director of LLC Company Helikon Ekaterina Vinogradova commented.
Meeting of Advisory council at Minpromtorg of Russia
The first day of work of the Forum comes to the end with key action - meeting of Advisory council at Minpromtorg of Russia on development of pharmaceutical industry under the chairmanship of the First Deputy Minister of Industry and Trade of the Russian Federation S. A. Tsyba on discussion of the draft of the Strategy of development of pharmaceutical industry till 2030. Following the results of action participants will prepare the statement for mass media.
On November 14 the memorandum of cooperation between Union of Pharmaceutical and Biomedical Clusters Non-profit partnership in OYuL in shape "Associations of Support and Development of Pharmaceutical Activity of the Republic of Kazakhstan" was signed.
Between CJSC Scientific Center of Examination of Drugs and Medical Technologies of Name of the Academician Emil Gabriyelyan of the Ministry of Health of the Republic of Armenia and Union of Pharmaceutical and Biomedical Clusters non-profit partnership the memorandum of understanding and cooperation was signed.
Press service of the Forum
"Life Sciences Invest. Partnering Russia"
+7 921 331 71 93 Svetlana Arshinnikova